p63 expression in epithelial ovarian tumors

International Journal of Gynecological Cancer

Volumn 16, Issue 1, 2006, Pages 152-155

  Poli Neto, O B ^a   Candido Dos Reis, F J ^a   Zambelli Ramalho, L N ^a   Nogueira, A A ^a   De Andrade, J M ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Carcinomas; Cystadenomas; Epithelial ovarian tumors; p63

Indexed keywords

MONOCLONAL ANTIBODY; PROTEIN P63;

ADULT; ARTICLE; BENIGN TUMOR; CARCINOGENESIS; CLEAR CELL CARCINOMA; CONTROLLED STUDY; CYSTADENOMA; ENDOMETRIOID CARCINOMA; EPITHELIUM; EPITHELIUM TUMOR; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALIGNANT NEOPLASTIC DISEASE; MUCINOUS CARCINOMA; OVARY CANCER; OVARY TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; UNDIFFERENTIATED CARCINOMA;

ADULT; AGE FACTORS; BIOPSY, NEEDLE; CARCINOMA; COHORT STUDIES; CYSTADENOMA; DNA-BINDING PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; IMMUNOHISTOCHEMISTRY; MIDDLE AGED; NEOPLASM STAGING; OVARIAN NEOPLASMS; PHOSPHOPROTEINS; PROBABILITY; PROGNOSIS; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; TISSUE CULTURE TECHNIQUES; TRANS-ACTIVATORS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEINS;

EID: 33645341451     PISSN: 1048891X     EISSN: 15251438     Source Type: Journal    
DOI: 10.1111/j.1525-1438.2006.00290.x     Document Type: Article

References (18)

1. Auersperg N Wong AST Choi KC Kang SK Leung PCK. Ovarian surface epithelium: biology, endocrinology, and pathology. Endocr Rev 2001 22 255 88.
2. American Cancer Society. Cancer facts and figures 2000. New York American Cancer Society Inc 2001.
3. Irwin MS Kaelin WG. Role of the newer p53 family members in malignancy. Apoptosis 2001 6 17 29.
4. Flores ER Tsai KY Crowley D et al. p63 and p73 are required for p53-dependent apoptosis in response to DNA damage. Nature 2002 416 560 4.
5. Irwin MS Kaelin WG. p53 family update: p73 and p63 develop their own identities. Cell Growth Differ 2001 12 337 49.
6. Ng SW Yiu GK Liu Y et al. Analysis of p73 in human borderline and invasive ovarian tumor. Oncogene 2000 19 1885 90.
7. Di Como CJ Urist MJ Bahayan I et al. p63 expression profiles in human normal and tumor tissues. Clin Cancer Res 2002 8 494 501.
8. Reis-Filho JS Simpson PT Martins A Preto A Gartner F Schmitt FC. Distribution of p63, cytokeratins 5/6 and cytokeratin 14 in 51 normal and 400 neoplastic human tissue samples using TARP-4 multi-tumor tissue microarray. Virchows Arch 2003 443 122 32.
9. International Federation of Gynecology and Obstetrics (FIGO). Classification and staging of malignant tumors in the female pelvis. Acta Obstet Gynecol Scand 1971 50 1 7.
10. Serov SF Scully RE Sobin LH. International histologic classification of tumours no. 9. Histological typing of ovarian tumours. Geneva World Health Organization 1973.
11. Caduff RF Svoboda-Newman SM Ferguson Awm Johnston CM Frank TS. Comparison of mutations of K-ras and p53 immunoreactivity in borderline and malignant epithelial ovarian tumors. Am J Surg Pathol 1999 23 323 8.
12. Scully RE Bell DA Abu-Jawdeh GM. Update on early ovarian cancer and cancer developing in benign ovarian tumors. In Feeley KM Wells M eds. Precursor lesions of ovarian epithelial malignancy. Histopathology 2001 38 87 95.
13. Watson RH Neville PJ Roy WJJ Hitchcock A Campbell IG. Loss of heterozygosity of chromosomes 7p, 7q, 9p and 11q is an early event in ovarian tumorigenesis. Oncogene 1998 17 207 12.
14. Strano S Fontemaggi G Costanzo A et al. Physical interaction with human tumor derived p53 mutants inhibits p63 activities. J Biol Chem 2002 277 18817 26.
15. Stiewe T Putzer BM. Role of p73 in malignancy: tumor suppressor or oncogene? Cell Death Differ 2002 9 237 45.
16. Kmet LM Cook LS Magliocco AM. A review of p53 expression and mutation in human benign, low malignant potential, and invasive epithelial ovarian tumors. Cancer 2003 97 389 404.
17. Calabro V Mansueto G Santoro R et al. Inhibition of p63 transcriptional activity by p14ARF: functional and physical link between human ARF tumor suppressor and a member of the p53 family. Mol Cell Biol 2004 24 8529 40.
18. Waltermann A Kartasheva NN Dobbelstein M. Differential regulation of p63 and p73 expression. Oncogene 2003 22 5686 93.